Liver function, including glutamic oxaloacetic transaminase (GOT) and glutamic pyruvictransaminase (GPT), of the CKD + AST-120 and CKD + CharXgen groups did not appear to have a significant change compared to the normal or sham groups (p > 0.05 for all, Figure 5 A,B). Here, GPT is linked to chronic kidney disease.